NYSEAMERICAN:CRHM - CRH Medical Stock Price, Forecast & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CRH Medical.

CRH Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for CRH Medical.

CRH Medical Corp (NYSEAMERICAN:CRHM) issued its quarterly earnings data on Wednesday, August, 1st. The company reported $0.02 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.01. The company had revenue of $27.33 million for the quarter, compared to analysts' expectations of $25.70 million. View CRH Medical's earnings history.

3 brokers have issued 12-month target prices for CRH Medical's stock. Their forecasts range from $4.00 to $4.75. On average, they anticipate CRH Medical's stock price to reach $4.38 in the next twelve months. This suggests a possible upside of 226.5% from the stock's current price. View analysts' price targets for CRH Medical.

Press coverage about CRHM stock has trended very negative this week, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a news impact score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutCRH Medical.

CRH Medical saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 11,600 shares, a drop of 38.6% from the February 27th total of 18,900 shares. Based on an average daily volume of 61,300 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the company's shares are sold short. View CRH Medical's Current Options Chain.

Some companies that are related to CRH Medical include Enerplus (ERF), Clover (CLV), Bovie Medical (BVX), Tristel (TSTL), InfuSystem (INFU), CRH Medical (CRH), Milestone Scientific (MLSS), SDI (SDI), Daxor (DXR), Daxor (DXR), Impression Healthcare (IHL), TSO3 (TOS), IsoRay (ISR), IsoRay (ISR) and Retractable Technologies (RVP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRH), AcelRx Pharmaceuticals (ACRX), Extreme Networks (EXTR), Pieris Pharmaceuticals (PIRS), NovaBay Pharmaceuticals (NBY), Palatin Technologies (PTN), Alimentation Couche-Tard (ATD.B), Dollarama (DOL), Abeona Therapeutics (ABEO) and Anavex Life Sciences (AVXL).

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CRHM stock can currently be purchased for approximately $1.34.

CRH Medical has a market capitalization of $95.96 million. CRH Medical employs 112 workers across the globe. View additional information about CRH Medical.

The official website for CRH Medical is http://investors.crhsystem.com/.

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.